NCT05122065

Menopausal Vaginal Microbiome

Defining the Vaginal Microbiome and the Vaginal pH of Menopausal Women With and Without Genitourinary Syndrome and With and Without Hormone Replacement Therapy

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 432 (estimated)
• Sponsor: FemTec Health Inc. · Industry
• Sex: Female
• Age: 40 Years – 70 Years
• Healthy volunteers: Accepted

Summary

In this study the investigators will analyze the vaginal microbiome of menopausal women in order to shed light on its potential implication on menopausal symptoms and quality of life. Moreover, the investigators will assess the effect of hormone replacement treatment on symptoms and overall quality of life during menopause and whether women under hormone replacement treatment have distinct vaginal microbiome profiles.

Conditions

• Menopause
• Hormone Replacement Therapy
• Genitourinary Syndrome of Menopause

Timeline

• Start date: 2021-12-01
• Primary completion: 2022-02-28
• Completion: 2022-12-15
• First posted: 2021-11-16
• Last updated: 2021-11-24